EMPAGLIFLOZIN, Placebo matching BI 690517, BI 690517
1378-0020
Phase 3 small_molecule active
Quick answer
EMPAGLIFLOZIN, Placebo matching BI 690517, BI 690517 for Heart failure (HF) is a Phase 3 program (small_molecule) at Boehringer Ingelheim International GmbH with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Boehringer Ingelheim International GmbH
- Indication
- Heart failure (HF)
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active